Low-Dose Decitabine in Myelodysplastic Syndrome Post Azacytidine Failure

Clinical trial NCT00113321 · TERMINATED

Trial details

NCT number: NCT00113321
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia

Start date: 2005-03-01
Primary completion: 2008-11-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.